IMPROVEMENTS IN SENSITIVITY FOR BIOANALYSIS OF WARFARIN USING ACQUITY™ PREMIER UPLC SYSTEM AND XEVO™ TQ ABSOLUTE TANDEM QUADRUPOLE MASS SPECTROMETER

Postery | 2022 | Waters | ASMSInstrumentace

LC/MS, LC/MS/MS, LC/QQQ

Zaměření

Farmaceutická analýza

Výrobce

Waters

Přejít do knihovny Zobrazit PDF

PDF verze ke stažení a čtení

Podobná PDF

Quantification of Warfarin and Furosemide in Human and Rat Plasma for Discovery Bioanalysis Using ACQUITY™ Premier UPLC™ System and Xevo™ TQ Absolute Mass Spectrometer

2022|Waters|Aplikace

Application Note Quantification of Warfarin and Furosemide in Human and Rat Plasma for Discovery Bioanalysis Using ACQUITY™ Premier UPLC™ System and Xevo™ TQ Absolute Mass Spectrometer Nikunj Tanna, Robert S. Plumb Waters Corporation Abstract Accurate and precise quantification of pharmaceutical…

Klíčová slova

furosemide, warfarin, premier, xevo, absolute, rat, bioanalysis, discovery, uplc, acquity, spectrometer, plasma, human, quantification, mass

Versatile LC-MS/MS Solutions for the Evolving Bioanalysis Landscape

2024|Waters|Příručky

[ APPLICATION NOTEBOOK ] Versatile LC-MS/MS Solutions for the Evolving Bioanalysis Landscape Small Molecules Oligonucleotide Protein/Peptide Therapeutics Software Tools Targeted Imaging LC-MS/MS Solutions to Support Reliable, Sensitive and Efficient Workflows for the Bioanalysis of Drug Modalities Welcome to the Waters…